Potential (18)F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy

PURPOSE: To investigate the ability of potential imaging biomarkers based on (18)F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography ((18)F-RGD PET/CT) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) imaging to predict the response to bevacizumab combined with conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Liu, Ning, Zhang, Hui, Tao, Rongjie, Zhao, Shuqiang, Chen, Zhaoqiu, Fu, Zheng, Li, Wanhu, Xu, Liang, Liu, Yuhui, Yu, Jinming, Yuan, Shuanghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459034/
https://www.ncbi.nlm.nih.gov/pubmed/36091179
http://dx.doi.org/10.3389/fonc.2022.848266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459034/
https://www.ncbi.nlm.nih.gov/pubmed/36091179
http://dx.doi.org/10.3389/fonc.2022.848266

Ejemplares similares